当前位置: 首页 > 期刊 > 《中医药学刊》 > 2008年第4期
编号:11584174
骨髓间充质干细胞移植治疗急性心肌梗死研究进展(3)
http://www.100md.com 2008年4月1日 《中华中医药学刊》 2008年第4期
     [13]Menasché P. Perspectives in cardiac cell therapy[J].Presse Med,2007,36 Spec No 1:1S55-8.

    [14]Gulati R,Simari RD. Cell therapy for acute myocardial infarction[J]. Med Clin North Am,2007,91(4):769-85.

    [15]Guo J,Lin G,Bao C,et al.Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction[J]. J Biomed Sci,2008,15(1):89-97.

    [16]Yang J,Zhou W. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction[J]. Cardiology,2007,107(1):17-29.

    [17]Chen J,Baydoun AR,Xu R,et al.Lysophosphatidic Acid Protects Mesenchymal Stem Cells against Hypoxia and Serum Deprivation-Induced Apoptosis[J]. Stem Cells,2007 Oct 11.

    [18]Canepa M,Coviello D,Chiarella F. Cardiac cell therapy: the puzzle is waiting to be solved[J].G Ital Cardiol (Rome),2006,7(4):252-265.

    [19]Tendera M,Wojakowski W. Clinical trials using autologous bone marrow and peripheral blood-derived progenitor cells in patients with acute myocardial infarction[J]. Folia Histochem Cytobiol,2005,43(4):233-235., 百拇医药(罗智博 田 苗)
上一页1 2 3